Stamcellscentrum (SCC)

Organisation: avdelning

Fler filtreringsmöjligheter
  1. The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia

    Kaderi, M. A., Murray, F., Jansson, M., Merup, M., Karlsson, K., Ross, G., Aleskog, A. & Tobin, G., 2008, I : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 32, 6, s. 984-987

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Cornelissen, J. J., Gratwohl, A., Schlenk, R. F., Sierra, J., Bornhaeuser, M., Gunnar Juliusson, Racil, Z., Rowe, J. M., Russell, N., Mohty, M., Lowenberg, B., Socie, G., Niederwieser, D. & Ossenkoppele, G. J., 2012, I : Nature Reviews Clinical Oncology. 9, 10, s. 579-590

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  3. The establishment of 20 different human embryonic stem cell lines and subclones; a report on derivation, culture, characterisation and banking

    Englund, M. C. O., Caisander, G., Noaksson, K., Emanuelsson, K., Lundin, K., Bergh, C., Hansson, C., Semb, H., Strehl, R. & Hyllner, J., 2010, I : In Vitro Cellular & Developmental Biology - Animal. 46, 3-4, s. 217-230

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential.

    Luc, S., Luis, T. C., Boukarabila, H., Macaulay, I. C., Buza-Vidas, N., Bouriez-Jones, T., Lutteropp, M., Woll, P. S., Loughran, S. J., Mead, A. J., Hultquist, A., Brown, J., Mizukami, T., Matsuoka, S., Ferry, H., Anderson, K., Duarte, S., Atkinson, D., Soneji, S., Domanski, A. & 10 andra, Farley, A., Sanjuan-Pla, A., Carella, C., Patient, R., de Bruijn, M., Enver, T., Nerlov, C., Blackburn, C., Godin, I. & Jacobsen, S. E. W., 2012, I : Nature Immunology. 13, 4, s. 412-419

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)

    Mohiuddin, G., Sausan A. Moharram, Marhäll, A. & Julhash U. Kazi, 2017 apr 28, I : Cancer Letters. 392, s. 9-16 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. The dual regulator Sufu integrates Hedgehog and Wnt signals in the early Xenopus embryo

    Hooi Min Tan Grahn, Kriebel, M., Hou, S. & Edgar Pera, 2011, I : Developmental Biology. 358, 1, s. 262-276

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. The Dkk1 dose is critical for eye development

    Lieven, O. & Ruether, U., 2011, I : Developmental Biology. 355, 1, s. 124-137

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. The CXCL12, periostin and CCL9 genes are direct targets for early B-cell factor (EBF) in OP-9 stroma cells.

    Lagergren, A., Månsson, R., Zetterblad, J., Emma Smith, Basta, B., David Bryder, Akerblad, P. & Mikael Sigvardsson, 2007, I : Journal of Biological Chemistry. 282, 19, s. 14454-14462

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift